ABCDEFGHIJKLMNOPQRSTUVWXYZAAAB
1
Impact Investing
2
Framework
3
4
1
Assumptions
5
6
Period Assumptions
7
Period Start
31-Aug-24
8
Period End Date
31-Aug-25
9
Total Investment (EURm)
10
10
Investment % Total Investment to Bring Product to Market
2.0%
11
Year of Product Launch
2032
12
13
Impact Assumptions (EURm)
14
Number of Patients
1,000,000
15
Incidence Growth Rate
1.0%
16
Initial Market Penetration
5.0%
17
Peak Market Penetration
25.0%
18
Incremental QALY Gained over SoC For Patients where Treatment is Effective
0.5
19
QALYs Value (EURm)
0.04
20
Total Financial Value of QALYs per Patient where Treatment is Effective
0.02
21
Hospital Savings Per Patient
0.05
22
Risk Adjustment
10.0%
23
24
Other Assumptions
25
Impact Discount Rate
10.0%
26
Terminal Value (TV) Growth Rate
0.0%
27
Terminal Value (TV) Discount Rate
80.0%
28
29
2
Impact Forecast
30
31
Period Start
8/31/20249/1/20259/1/20269/1/20279/1/20289/1/20299/1/20309/1/20319/1/20329/1/20339/1/20349/1/20359/1/20369/1/20379/1/20389/1/20399/1/20409/1/2041
32
Period End
8/31/20258/31/20268/31/20278/31/20288/31/20298/31/20308/31/20318/31/20328/31/20338/31/20348/31/20358/31/20368/31/20378/31/20388/31/20398/31/20408/31/20418/31/2042
33
Days in Period
366365365366365365365366365365365366365365365366365365
34
YearFY25FY26FY27FY28FY29FY30FY31FY32FY33FY34FY35FY36FY37FY38FY39FY40FY41FY42
35
36
Forecast (EURm)
37
38
December YE
Unit2024E2025E2026E2027E2028E2029E2030E2031E2032E2033E2034E2035E2036E2037E2038E2039E2040E2041E
39
40
Number of Patients
1,000,0001,010,0001,020,1001,030,3011,040,6041,051,0101,061,5201,072,1351,082,8571,093,6851,104,6221,115,6681,126,8251,138,0931,149,4741,160,9691,172,579
41
Market Penetration
%5.0%9.0%13.0%17.0%21.0%25.0%25.0%25.0%25.0%25.0%
42
Patients Treated
#53,60797,457142,179187,786234,290281,706284,523287,369290,242293,145
43
44
Total Financial Impact of QALYs
#1,0721,9492,8443,7564,6865,6345,6905,7475,8055,863
45
Risk Adjusted Total Financial Impact of QALYs
#107195284376469563569575580586
46
Impact Discount Rate
%10.0%10.0%10.0%10.0%10.0%10.0%10.0%10.0%10.0%10.0%
47
Present Value of Risk Adjusted Financial Impact of QALYs
#4575100120136148136125115105
48
49
Cost Reductions to Hospitals
#2,6804,8737,1099,38911,71514,08514,22614,36814,51214,657
50
Risk Adjusted Cost Reductions to Hospitals
#2684877119391,1711,4091,4231,4371,4511,466
51
Impact Discount Rate
%10.0%10.0%10.0%10.0%10.0%10.0%10.0%10.0%10.0%10.0%
52
Present Value of Cost Reductions
#114188249300339371340314287263
53
54
Total Present Value of Financial Impact
#1592633494204755194764394023692,052
55
56
Sum Present Value of Financial Impact by 2040
3,870
57
Terminal Value
2,565
58
Present Value of Terminal Value
461
59
Actual Ownership of Impact
87
60
Initial Investment
10
61
Social Impact Made where 1 EUR invested yields:
8.7 EUR
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100